Company Analysis TriSalus Life Sciences Inc.
1. Summary
Advantages
- Price (1.25 $) is less than fair price (1.42 $)
- The stock's return over the last year (14.29%) is higher than the sector average (0%).
Disadvantages
- Dividends (0%) are below the sector average (0%).
- The company's current efficiency (ROE=113.47%) is lower than the sector average (ROE=253.66%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| TriSalus Life Sciences Inc. | Index | ||
|---|---|---|---|
| 7 days | 28% | 0.7% | -1.3% |
| 90 days | 28% | -0.6% | -0.3% |
| 1 year | 14.3% | 0% | 14.2% |
TLSIW vs Sector: TriSalus Life Sciences Inc. has outperformed the "" sector by 14.29% over the past year.
TLSIW vs Market: TriSalus Life Sciences Inc. has outperformed the market by 0.0755% over the past year.
Stable price: TLSIW is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TLSIW with weekly volatility of 0.27% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (1.25 $) is lower than the fair price (1.42 $).
Price not significantly lower than the fair price: The current price (1.25 $) is slightly lower than the fair price by 13.6%.
5.2. P/E
P/E vs Sector: The company's P/E (-1.72) is higher than that of the sector as a whole (-335.61).
P/E vs Market: The company's P/E (-1.72) is higher than that of the market as a whole (-104.3).
5.3. P/BV
P/BV vs Sector: The company's P/BV (-1.34) is higher than that of the sector as a whole (-1320.1).
P/BV vs Market: The company's P/BV (-1.34) is lower than that of the market as a whole (72.17).
5.5. P/S
P/S vs Sector: The company's P/S indicator (1.18) is lower than that of the sector as a whole (28.76).
P/S vs Market: The company's P/S indicator (1.18) is lower than that of the market as a whole (114).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (0) is higher than that of the sector as a whole (-870.14).
EV/Ebitda vs Market: The company's EV/Ebitda (0) is higher than that of the market as a whole (-78.04).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 0.83% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (0.83%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-46.03%).
6.4. ROE
ROE vs Sector: The company's ROE (113.47%) is lower than that of the sector as a whole (253.66%).
ROE vs Market: The company's ROE (113.47%) is higher than that of the market as a whole (-6.22%).
6.6. ROA
ROA vs Sector: The company's ROA (-123.72%) is lower than that of the sector as a whole (-37.56%).
ROA vs Market: The company's ROA (-123.72%) is lower than that of the market as a whole (38.45%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (9.79%).
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Based on sources: porti.ru
MAX


